One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Time trends in preemptive kidney transplantation in Europe: ERA Registry Figure of the month Open Access
doi : 10.1093/ckj/sfaf304
Volume 18, Issue 9, September 2025
Anemia and iron deficiency in post-kidney transplantation: an unsolved challenge Open Access
doi : 10.1093/ckj/sfaf252
Hypertension burden in CKD: is nocturnal hypertension the primary culprit? Open Access
doi : 10.1093/ckj/sfaf229
The impact of metabolic dysfunction-associated steatotic liver disease (MASH) on the high risk of cardiovascular disease in CKD: interconnections and management Open Access
doi : 10.1093/ckj/sfaf260
Bioengineered T-cell therapies for precision immunotherapy in renal transplantation, autoimmune relapse, and sensitization Open Access
doi : 10.1093/ckj/sfaf248
10 tips on how to take a proper family history in CKD patient care Open Access
doi : 10.1093/ckj/sfaf253
Global burden and trends of stroke attributable to kidney dysfunction from 1990 to 2021 Open Access
doi : 10.1093/ckj/sfaf160
Identification of early predictors of clinical remission in primary membranous nephropathy: a post hoc analysis of the STARMEN trial Open Access
doi : 10.1093/ckj/sfaf256
Telitacicept versus mycophenolate mofetil in IgA nephropathy: a real-world comparative study of efficacy, renal outcomes and safety Open Access
doi : 10.1093/ckj/sfaf261
Kidney Failure Risk Equation performance according to the etiology of chronic kidney disease in the CKD-CAREMEAU cohort Open Access
doi : 10.1093/ckj/sfaf258
Classical and mannose-binding lectin complement pathway activation in patients with ANCA-associated vasculitis Open Access
doi : 10.1093/ckj/sfaf249
Novel therapies improve prognosis of IgAN and limit the applicability of the International IgA Nephropathy Prediction Tool Open Access
doi : 10.1093/ckj/sfaf251
The Portuguese Albuminuria Study: national insights into prevalence and risk factors Open Access
doi : 10.1093/ckj/sfaf240
Predicting prognosis in ANCA-associated vasculitis with kidney involvement Open Access
doi : 10.1093/ckj/sfaf268
A novel CT-based radiomics approach for kidney function evaluation in ADPKD: a pilot study Open Access
doi : 10.1093/ckj/sfaf264
Clinical applications and limitations of large language models in nephrology: a systematic review Open Access
doi : 10.1093/ckj/sfaf243
But how green is it actually? Calculating the environmental footprint of kidney care environmental optimizations within haemodialysis Open Access
doi : 10.1093/ckj/sfaf220
Drivers of hospital costs in ANCA-associated vasculitis patients with long-term follow-up—a real-world cost analysis Open Access
doi : 10.1093/ckj/sfaf267
Management and treatment of chronic kidney disease in the Danish Lolland-Falster Health Study: focus on renoprotection and cardiovascular disease prevention Open Access
doi : 10.1093/ckj/sfaf242
The impact of hemoadsorption in patients with chronic kidney disease undergoing coronary artery bypass grafting Open Access
doi : 10.1093/ckj/sfaf241
Effect of spironolactone on cardiovascular and renal outcomes in patients with chronic kidney disease Open Access
doi : 10.1093/ckj/sfaf247
The Swedish Renal Registry: a nationwide registry for chronic kidney disease of all stages Open Access
doi : 10.1093/ckj/sfaf238
Exploring the relationship between serum magnesium levels, genetic variants and chronic kidney disease: a prospective study Open Access
doi : 10.1093/ckj/sfaf254
Social deprivation as a key driver of spatial disparities in end-stage kidney disease incidence Open Access
doi : 10.1093/ckj/sfaf266
Empagliflozin and fluid balance: results from the SiRENA project Open Access
doi : 10.1093/ckj/sfaf262
Dapagliflozin use in tolvaptan-treated patients with ADPKD: exploring renal outcomes in a retrospective study Open Access
doi : 10.1093/ckj/sfaf269
Concordance of symptoms perceived by patients receiving haemodialysis and those reported by nurses and nephrologists: a cross-sectional, multicentre, observational study using the REIN registry Open Access
doi : 10.1093/ckj/sfaf239
Effect of dialysate bicarbonate on calciprotein particle crystallization time (T50) in hemodialysis patients—the D-Bic study Open Access
doi : 10.1093/ckj/sfaf263
Difelikefalin for CKD-aP: real world evidence of efficacy and safety in Italian patients Open Access
doi : 10.1093/ckj/sfaf050
Growth hormone treatment associates with improved circulating anti-aging protein Klotho and reduced arterial stiffness in children with CKD Open Access
doi : 10.1093/ckj/sfaf231
Kidney interstitial edema as the central pathophysiological mechanism of NSAKI: a call for reappraisal Open Access
doi : 10.1093/ckj/sfaf271
Correction to: Decongestion in patients with advanced chronic kidney disease coexisting with heart failure Open Access
doi : 10.1093/ckj/sfaf288
Correction to: Spatially resolved transcriptomic profiling for glomerular and tubulointerstitial gene expression in C3 glomerulopathy Open Access
doi : 10.1093/ckj/sfaf257
Correction to: The burden of acute kidney disease: an epidemiological review and importance of follow-up care Open Access
doi : 10.1093/ckj/sfaf277
Correction to: A clinical score to predict recovery in end-stage kidney disease due to acute kidney injury Open Access
doi : 10.1093/ckj/sfaf299
